Cambridge Investment Research Advisors Inc. Acquires 410 Shares of BlackRock Health Sciences Trust (NYSE:BME)

Cambridge Investment Research Advisors Inc. raised its holdings in BlackRock Health Sciences Trust (NYSE:BMEFree Report) by 0.8% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 50,106 shares of the company’s stock after purchasing an additional 410 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in BlackRock Health Sciences Trust were worth $2,027,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of BME. Stonebridge Capital Advisors LLC bought a new stake in BlackRock Health Sciences Trust in the 3rd quarter valued at about $31,000. Farmers & Merchants Investments Inc. bought a new stake in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $40,000. Truist Financial Corp bought a new stake in shares of BlackRock Health Sciences Trust during the 4th quarter worth approximately $213,000. HBK Sorce Advisory LLC lifted its holdings in shares of BlackRock Health Sciences Trust by 4.2% during the 4th quarter. HBK Sorce Advisory LLC now owns 6,125 shares of the company’s stock worth $248,000 after acquiring an additional 249 shares during the period. Finally, L.M. Kohn & Company lifted its holdings in shares of BlackRock Health Sciences Trust by 9.9% during the 4th quarter. L.M. Kohn & Company now owns 7,782 shares of the company’s stock worth $315,000 after acquiring an additional 704 shares during the period.

BlackRock Health Sciences Trust Stock Up 1.4 %

Shares of BlackRock Health Sciences Trust stock opened at $40.45 on Tuesday. The company has a 50 day moving average of $39.82 and a 200-day moving average of $40.49. BlackRock Health Sciences Trust has a 1-year low of $35.53 and a 1-year high of $42.86.

BlackRock Health Sciences Trust Announces Dividend

The company also recently declared a monthly dividend, which was paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th were issued a dividend of $0.213 per share. This represents a $2.56 dividend on an annualized basis and a dividend yield of 6.32%. The ex-dividend date of this dividend was Tuesday, May 14th.

BlackRock Health Sciences Trust Company Profile

(Free Report)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Recommended Stories

Institutional Ownership by Quarter for BlackRock Health Sciences Trust (NYSE:BME)

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.